What is PT-141?
PT-141, also known as bremelanotide, is a synthetic melanocortin analog. Unlike PDE5 inhibitors, it acts on central nervous system pathways involved in desire rather than on blood flow.
Sexual Wellness
PT‑141
A melanocortin receptor agonist that acts centrally rather than on vascular pathways.
- Format
- 50mg vial — 10mg/mL, 5mL injectable
- Price
- $210 per vial
- Route
- Injectable / Nasal
- Evidence level
- Established
- Regulatory status
- Off-Label
- Testing
- Provider Determines Testing
Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
Understanding PT-141
Format & administration
Used as needed, typically dosed several hours before intended activity, via subcutaneous injection or nasal spray.
Testing posture
Your doctor determines the final testing requirements for PT-141 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
How it works
How PT-141 works
- 01PT-141 activates melanocortin receptors — principally MC4R — in the hypothalamus, influencing the neural signaling associated with sexual desire and arousal.
Show illustration: PT-141 (Bremelanotide)
What has been studied
Potential applications and evidence
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
Explored for libido and desire in men and women
Discussed where vascular-focused options are insufficient
Used on demand rather than daily
Potential support alongside hormone optimization
Doctor-guided
A personalized approach
Your doctor determines the final testing requirements for PT-141 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status: Provider Determines Testing
Commonly reviewed at baseline
- Blood pressure review
- Comprehensive metabolic panel (CMP)
- Hormone panel if indicated
Follow-up & monitoring
Blood pressure and tolerance are reviewed after the first doses; labs are repeated only if your doctor sees a reason.
Medication review
Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Format & dosing
Used as needed, typically dosed several hours before intended activity, via subcutaneous injection or nasal spray.
Safety
What patients should know
- Compounded, not FDA-approved in this form. Transient nausea, flushing, and blood pressure changes are reported. Patients with uncontrolled hypertension or cardiovascular disease require careful review.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Uncontrolled hypertension
- Known cardiovascular disease without clearance
Regulatory status: Off-Label. Evidence level: Established. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.
Common questions
Frequently asked questions
Ready when you are
Find out what your body is actually asking for.
Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.